Lipidomic UPLC-MS/MS Profiles of Normal-Appearing White Matter Differentiate Primary and Secondary Progressive Multiple Sclerosis

POUSINIS, Petros, RAMOS, Ines R., WOODROOFE, M. Nicola and COLE, Laura M. (2020). Lipidomic UPLC-MS/MS Profiles of Normal-Appearing White Matter Differentiate Primary and Secondary Progressive Multiple Sclerosis. Metabolites, 10 (9), e366.

[img]
Preview
PDF
metabolites-10-00366-v2.pdf - Published Version
Creative Commons Attribution.

Download (2MB) | Preview
Official URL: https://www.mdpi.com/2218-1989/10/9/366
Link to published version:: https://doi.org/10.3390/metabo10090366
Related URLs:

    Abstract

    Multiple sclerosis (MS) is a neurodegenerative inflammatory disease where an autoimmune response to components of the central nervous system leads to a loss of myelin and subsequent neurological deterioration. People with MS can develop primary or secondary progressive disease (PPMS, SPMS) and differentiation of the specific differences in the pathogenesis of these two courses, at the molecular level, is currently unclear. Recently, lipidomics studies using human biofluids, mainly plasma and cerebrospinal fluid, have highlighted a possible role for lipids in the initiation and progression of MS. However, there is a lack of lipidomics studies in MS on CNS tissues, such as normal-appearing white matter (NAWM), where local inflammation initially occurs. Herein, we developed an untargeted reverse phase ultra-performance liquid chromatography time of flight tandem mass spectrometry (RP-UPLC-TOF MSE)-based workflow, in combination with multivariate and univariate statistical analysis, to assess significant differences in lipid profiles in brain NAWM from post-mortem cases of PPMS, SPMS and controls. Groups of eight control, nine PPMS and seven SPMS NAWM samples were used. Correlation analysis of the identified lipids by RP-UPLC-TOF MSE was undertaken to remove those lipids that correlated with age, gender and post-mortem interval as confounding factors. We demonstrate that there is a significantly altered lipid profile of control cases compared with MS cases and that progressive disease, PPMS and SPMS, can be differentiated on the basis of the lipidome of NAWM with good sensitivity, specificity and prediction accuracy based on receiver operating characteristic (ROC) curve analysis. Metabolic pathway analysis revealed that the most altered lipid pathways between PPMS and SPMS were glycerophospholipid metabolism, glycerophosphatidyl inositol (GPI) anchor synthesis and linoleic acid metabolism. Further understanding of the impact of these lipid alterations described herein associated with progression will provide an increased understanding of the mechanisms underpinning progression and highlight possible new therapeutic targets.

    Item Type: Article
    Additional Information: ** From MDPI via Jisc Publications Router ** Licence for this article: https://creativecommons.org/licenses/by/4.0/ **Journal IDs: eissn 2218-1989 **History: published 08-09-2020; accepted 07-09-2020
    Uncontrolled Keywords: multiple sclerosis, progression, lipidomics, neurodegeneration, glycerophospholipids
    Identification Number: https://doi.org/10.3390/metabo10090366
    Page Range: e366
    SWORD Depositor: Colin Knott
    Depositing User: Colin Knott
    Date Deposited: 11 Sep 2020 16:28
    Last Modified: 11 Sep 2020 16:28
    URI: http://shura.shu.ac.uk/id/eprint/27195

    Actions (login required)

    View Item View Item

    Downloads

    Downloads per month over past year

    View more statistics